Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes
Authors
Keywords
-
Journal
SCIENCE
Volume 359, Issue 6379, Pages 1037-1042
Publisher
American Association for the Advancement of Science (AAAS)
Online
2018-03-02
DOI
10.1126/science.aar3246
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long-Lasting Complete Responses in Patients with Metastatic Melanoma after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes and an Attenuated IL2 Regimen
- (2016) R. Andersen et al. CLINICAL CANCER RESEARCH
- The neonatal Fc receptor, FcRn, as a target for drug delivery and therapy
- (2015) Jonathan T. Sockolosky et al. ADVANCED DRUG DELIVERY REVIEWS
- Synergistic Innate and Adaptive Immune Response to Combination Immunotherapy with Anti-Tumor Antigen Antibodies and Extended Serum Half-Life IL-2
- (2015) Eric F. Zhu et al. CANCER CELL
- Antibodies to Interleukin-2 Elicit Selective T Cell Subset Potentiation through Distinct Conformational Mechanisms
- (2015) Jamie B. Spangler et al. IMMUNITY
- Adoptive cell transfer as personalized immunotherapy for human cancer
- (2015) S. A. Rosenberg et al. SCIENCE
- Remote control of therapeutic T cells through a small molecule-gated chimeric receptor
- (2015) C.-Y. Wu et al. SCIENCE
- Two Functionally Distinct Subsets of Mast Cells Discriminated By IL-2–Independent CD25 Activities
- (2014) Lorenzo Deho’ et al. JOURNAL OF IMMUNOLOGY
- IL-2: The First Effective Immunotherapy for Human Cancer
- (2014) S. A. Rosenberg JOURNAL OF IMMUNOLOGY
- Generation of bispecific IgG antibodies by structure-based design of an orthogonal Fab interface
- (2014) Steven M Lewis et al. NATURE BIOTECHNOLOGY
- Synthetic control of mammalian-cell motility by engineering chemotaxis to an orthogonal bioinert chemical signal
- (2014) J. S. Park et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A bump-and-hole approach to engineer controlled selectivity of BET bromodomain chemical probes
- (2014) M. G. J. Baud et al. SCIENCE
- Adoptive T Cell Transfer for Cancer Immunotherapy in the Era of Synthetic Biology
- (2013) Michael Kalos et al. IMMUNITY
- Exploiting a natural conformational switch to engineer an interleukin-2 ‘superkine’
- (2012) Aron M. Levin et al. NATURE
- Control of protein signaling using a computationally designed GTPase/GEF orthogonal pair
- (2012) G. T. Kapp et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
- (2010) Kaori Sakuishi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Alternate States of Proteins Revealed by Detailed Energy Landscape Mapping
- (2010) Michael D. Tyka et al. JOURNAL OF MOLECULAR BIOLOGY
- Computer-aided design of functional protein interactions
- (2009) Daniel J Mandell et al. Nature Chemical Biology
- The Biology of Interleukin-2
- (2007) Thomas R. Malek Annual Review of Immunology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started